Abstract:Neurodegenerative diseases (NDDs) are a collection of incapacitating disorders in which neuroinflammation and neuronal apoptosis are major pathological consequences due to oxidative stress. Neuroinflammation manifests in the impacted cerebral areas as a result of pro-inflammatory cytokines stimulating the Janus Kinase2 (JAK2)/Signal Transducers and Activators of Transcription3 (STAT3) pathway via neuronal cells. The pro-inflammatory cytokines bind to their respective receptor in the neuronal cells and allow activation of JAK2. Activated JAK2 phosphorylates tyrosines on the intracellular domains of the receptor which recruit the STAT3 transcription factor. The neuroinflammation issues are exacerbated by the active JAK2/STAT3 signaling pathway in conjunction with additional transcription factors like nuclear factor kappa B (NF-κB), and the mammalian target of rapamycin (mTOR). Neuronal apoptosis is a natural process made worse by persistent neuroinflammation and immunological responses via caspase-3 activation. The dysregulation of micro-RNA (miR) expression has been observed in the consequences of neuroinflammation and neuronal apoptosis. Neuroinflammation and neuronal apoptosis-associated gene amplification may be caused by dysregulated miR-mediated aberrant phosphorylation of JAK2/STAT3 signaling pathway components. Therefore, JAK2/STAT3 is an attractive therapeutic target for NDDs. Numerous synthetic and natural small molecules as JAK2/STAT3 inhibitors have therapeutic advances against a wide range of diseases, and many are now in human clinical studies. This review explored the interactive role of the JAK2/STAT3 signaling system with key pathological factors during the reinforcement of NDDs. Also, the clinical trial data provides reasoning evidence about the possible use of JAK2/STAT3 inhibitors to abate neuroinflammation and neuronal apoptosis in NDDs.

Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders

JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

Targeting STATs in Neuroinflammation: the Road Less Traveled!

JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia

Neuroinflammation: A Critical Factor in Neurodegenerative Disorders

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

The Role of the JAK-STAT Pathway in Neural Stem Cells, Neural Progenitor Cells and Reactive Astrocytes after Spinal Cord Injury.

Regulation of the JAK/STAT Signaling Pathway in Spinal Cord Injury: an Updated Review

SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options

Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons

NF-κB and JAK/STAT Signaling Pathways as Crucial Regulators of Neuroinflammation and Astrocyte Modulation in Spinal Cord Injury

Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders

JAK/STAT Signaling Predominates in Human and Murine Fungal Post-infectious Inflammatory Response Syndrome

The Role of STATs in Inflammation and Inflammatory Diseases

Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases